Company profile
GI therapeutics | Rare Diseases | Atlantic Healthcare
We are a specialist pharmaceutical company focused on developing & commercializing therapeutics that address unmet patient needs & rare diseases.
Updated 06 Jun 2026 16:52
Financial period: 1 Jan 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQzNjgxNDAzNGFkaXF6a2N4
Published 23 Sep 2024 09:29
AA01 | Transaction MzQzNjUwMzQzOWFkaXF6a2N4
Published 19 Sep 2024 09:09
Company registered at Companies House
